The inflammatory milieu in idiopathic inflammatory myositis

Current Rheumatology Reports

Volumn 11, Issue 4, 2009, Pages 295-301

  Reed, Ann M ^a   Ernste, Floranne ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; INTERFERON; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL FUNCTION; CELL STRUCTURE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMATOMYOSITIS; HUMAN; IDIOPATHIC DISEASE; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; INFLAMMATORY DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MONONUCLEAR CELL; MYOSITIS; NATURAL KILLER CELL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

AUTOIMMUNITY; CHEMOKINES; HUMANS; IMMUNITY, CELLULAR; MUSCLE CELLS; MYOSITIS;

EID: 70449631452     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0041-1     Document Type: Review

References (67)

1. B.M. Feldman L.G. Rider A.M. Reed L.M. Pachman 2008 Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood Lancet 371 2201 2212 18586175 10.1016/S0140-6736(08)60955-1 (Pubitemid 351890413)
2. M.C. Dalakas R. Hohlfeld 2003 Polymyositis and dermatomyositis Lancet 362 971 982 14511932 10.1016/S0140-6736(03)14368-1 1:CAS:528:DC%2BD3sXnsVWqu7g%3D (Pubitemid 37159295)
3. M.C. Dalakas K. Sivakumar 1996 The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis Curr Opin Neurol 9 235 239 8839618 10.1097/00019052-199606000-00015 1:STN:280:DyaK28vjs1yjsA%3D%3D
4. G. Page G. Chevrel P. Miossec 2004 Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells Arthritis Rheum 50 199 208 14730617 10.1002/art.11428 1:CAS:528:DC%2BD2cXht1Kru7k%3D (Pubitemid 38084305)
5. R. Hohlfeld N. Goebels A.G. Engel 1993 Cellular mechanisms in inflammatory myopathies Baillieres Clin Neurol 2 617 635 8156145 1:STN:280:DyaK2c3gslCruw%3D%3D
6. J.N. Whitaker W.K. Engel 1972 Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy N Engl J Med 286 333 338 4550387 1:STN:280:DyaE38%2FovF2luw%3D%3D
7. C.M. López de Padilla A.N. Vallejo D. Lacomis, et al. 2009 Extra-nodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis Arthritis Rheum 60 1160 1172 19333937 10.1002/art.24411
8. A.G. Engel K. Arahata 1986 Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies Hum Pathol 17 704 721 3459704 10.1016/S0046-8177(86)80180-0 1:STN:280:DyaL283kvFamsQ%3D%3D
9. J.L. De Bleecker A.G. Engel E.C. Butcher 1996 Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies Neuromuscul Disord 6 255 260 8887954 10.1016/0960-8966(96)00015-6 (Pubitemid 26325321)
10. C.M. Lopez de Padilla A.N. Vallejo K.T. McNallan, et al. 2007 Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis Arthritis Rheum 56 1658 1668 17469160 10.1002/art.22558 (Pubitemid 46764095)
11. S.A. Greenberg J.L. Pinkus G.S. Pinkus, et al. 2005 Interferon-alpha/ beta-mediated innate immune mechanisms in dermatomyositis Ann Neurol 57 664 678 15852401 10.1002/ana.20464 1:CAS:528:DC%2BD2MXkvFykt78%3D (Pubitemid 40628855)
12. S.A. Greenberg G.S. Pinkus A.A. Amato J.L. Pinkus 2007 Myeloid dendritic cells in inclusion-body myositis and polymyositis Muscle Nerve 35 17 23 16969836 10.1002/mus.20649 1:CAS:528:DC%2BD2sXhsVOnt7s%3D (Pubitemid 46052644)
13. L.A. Tesmer S.K. Lundy S. Sarkar D.A. Fox 2008 Th17 cells in human disease Immunol Rev 223 87 113 18613831 10.1111/j.1600-065X.2008.00628.x 1:CAS:528:DC%2BD1cXptlGls7s%3D (Pubitemid 351986173)
14. E. Bettelli T. Korn M. Oukka V.K. Kuchroo 2008 Induction and effector functions of T(H)17 cells Nature 453 1051 1057 18563156 10.1038/nature07036 1:CAS:528:DC%2BD1cXntlGjtbo%3D (Pubitemid 351871737)
15. C. Dong 2008 TH17 cells in development: an updated view of their molecular identity and genetic programming Nat Rev Immunol 8 337 348 18408735 10.1038/nri2295 1:CAS:528:DC%2BD1cXltFejsb0%3D (Pubitemid 351595217)
16. K. Ikezoe S. Ohshima M. Osoegawa, et al. 2006 Expression of granulysin in polymyositis and inclusion-body myositis J Neurol Neurosurg Psychiatry 77 1187 1190 16980658 10.1136/jnnp.2005.081810 1:STN:280:DC%2BD28rlsVOlsg%3D%3D (Pubitemid 44453256)
17. G. Page A. Sattler S. Kersten, et al. 2004 Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression Am J Pathol 164 409 417 14742247 1:CAS:528:DC%2BD2cXhsFGqs7o%3D
18. G. Chevrel G. Page C. Granet, et al. 2003 Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis J Neuroimmunol 137 125 133 12667656 10.1016/S0165-5728(03)00032-8 1:CAS:528:DC%2BD3sXitlGhtL4%3D (Pubitemid 36351574)
19. G. Chevrel C. Granet P. Miossec 2005 Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors Ann Rheum Dis 64 1257 1262 15731288 10.1136/ard.2004.032359 1:CAS:528:DC%2BD2MXhtVChu7%2FF (Pubitemid 41206239)
20. J.L. De Bleecker A.G. Engel 1995 Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies Am J Pathol 146 1178 1187 7747812
21. M. Colonna G. Trinchieri Y.J. Liu 2004 Plasmacytoid dendritic cells in immunity Nat Immunol 5 1219 1226 15549123 10.1038/ni1141 1:CAS:528: DC%2BD2cXpvV2rsbg%3D (Pubitemid 41057736)
22. T.A. Griffin A.M. Reed 2007 Pathogenesis of myositis in children Curr Opin Rheumatol 19 487 491 17762616 10.1097/BOR.0b013e32825a6a57 1:CAS:528:DC%2BD2sXpvVentr8%3D (Pubitemid 47344243)
23. E.C. Baechler J.W. Bauer C.A. Slattery, et al. 2007 An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity Mol Med 13 59 68 17515957 10.2119/2006-00085.Baechler 1:CAS:528:DC%2BD2sXmt12rsLg%3D (Pubitemid 46786834)
24. S.A. Greenberg E.M. Bradshaw J.L. Pinkus, et al. 2005 Plasma cells in muscle in inclusion body myositis and polymyositis Neurology 65 1782 1787 16344523 10.1212/01.wnl.0000187124.92826.20 1:STN:280:DC%2BD2Mnmt1GntA%3D%3D (Pubitemid 43754412)
25. K. Arahata A.G. Engel 1984 Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells Ann Neurol 16 193 208 6383191 10.1002/ana.410160206 1:STN:280: DyaL2czgsFOgsQ%3D%3D
26. E.M. Bradshaw A. Orihuela S.L. McArdel, et al. 2007 A local antigen-driven humoral response is present in the inflammatory myopathies J Immunol 178 547 556 17182595 1:CAS:528:DC%2BD2sXnvVCj
27. K.M. Rostasy M. Piepkorn H.H. Goebel, et al. 2004 Monocyte/macrophage differentiation in dermatomyositis and polymyositis Muscle Nerve 30 225 230 15266639 10.1002/mus.20088 (Pubitemid 38982227)
28. P. Confalonieri P. Bernasconi P. Megna, et al. 2000 Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies J Neuropathol Exp Neurol 59 164 169 10749105 1:STN:280:DC%2BD3c3htVKlsQ%3D%3D
29. B. De Paepe J.L. De Bleecker 2005 Beta-chemokine receptor expression in idiopathic inflammatory myopathies Muscle Nerve 31 621 627 15772970 10.1002/mus.20294 (Pubitemid 40577785)
30. M. Civatte C. Bartoli N. Schleinitz, et al. 2005 Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies Neuropathol Appl Neurobiol 31 70 79 15634233 10.1111/j.1365-2990. 2004.00591.x 1:CAS:528:DC%2BD2MXitVamsLY%3D (Pubitemid 40222827)
31. K.M. Rostasy J. Schmidt E. Bahn, et al. 2008 Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies Acta Myol 27 49 53 19364061 1:STN:280:DC%2BD1M3nsFagtQ%3D%3D
32. K. Arahata A.G. Engel 1988 Monoclonal antibody analysis of mononuclear cells in myopathies. IV: cell-mediated cytotoxicity and muscle fiber necrosis Ann Neurol 23 168 173 3288082 10.1002/ana.410230210 1:STN:280: DyaL1c3jvFCktQ%3D%3D
33. A. Mitsuo S. Morimoto Y. Nakiri, et al. 2006 Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases Rheumatology (Oxford) 45 1477 1484 10.1093/rheumatology/kel119 1:STN:280:DC%2BD28notlCqtw%3D%3D (Pubitemid 44817052)
34. M.R. O'Gorman L. Bianchi D. Zaas, et al. 2000 Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis Clin Diagn Lab Immunol 7 693 697 10882674
35. K. W. McNallan C. Crowson A.M. Reed 2007 Absence of killer Ig-like inhibitory receptor with the associated HLA ligand in juvenile dermatomyositis Arthritis Rheum 56 9S 10.1002/art.22315 (Pubitemid 46106173)
36. C.K. Li H. Varsani J.L. Holton, et al. 2004 MHC class I overex-pression on muscles in early juvenile dermatomyositis J Rheumatol 31 605 609 14994413 1:CAS:528:DC%2BD2cXislKrtLY%3D
37. K. Nagaraju 2005 Role of major histocompatibility complex class I molecules in autoimmune myositis Curr Opin Rheumatol 17 725 730 16224250 10.1097/01.bor.0000179947.58271.9a 1:CAS:528:DC%2BD2MXhtFSis7zI (Pubitemid 41546491)
38. J. van der Pas G.J. Hengstman H.J. ter Laak, et al. 2004 Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies J Neurol Neurosurg Psychiatry 75 136 139 14707323
39. H. Wiendl M. Mitsdoerffer V. Hofmeister, et al. 2003 The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy Brain 126 Pt1 176 185 12477705 10.1093/brain/awg017 (Pubitemid 36068568)
40. H. Wiendl M. Mitsdoerffer D. Schneider, et al. 2003 Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies Faseb J 17 1892 1894 12923066 1:CAS:528: DC%2BD3sXot1Kitr4%3D
41. K. Nagaraju L. Casciola-Rosen I. Lundberg, et al. 2005 Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction Arthritis Rheum 52 1824 1835 15934115 10.1002/art.21103 1:CAS:528:DC%2BD2MXlvFChurY%3D (Pubitemid 40852891)
42. L. Behrens A. Bender M.A. Johnson R. Hohlfeld 1997 Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells Brain 120 Pt6 929 938 9217678 10.1093/brain/120.6. 929 (Pubitemid 27259544)
43. D.S. Tews H.H. Goebel 1998 Cell death and oxidative damage in inflammatory myopathies Clin Immunol Immunopathol 87 240 247 9646833 10.1006/clin.1998.4527 1:CAS:528:DyaK1cXktleitr4%3D (Pubitemid 28285439)
44. A.K. Ulfgren C. Grundtman K. Borg, et al. 2004 Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids Arthritis Rheum 50 1586 1594 15146429 10.1002/art.20220 1:CAS:528:DC%2BD2cXkvFyrs70%3D (Pubitemid 38608081)
45. I. Lundberg A.K. Kratz H. Alexanderson M. Patarroyo 2000 Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis Arthritis Rheum 43 336 348 10693873 10.1002/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V 1:CAS:528:DC%2BD3cXhs1aqtb4%3D (Pubitemid 30395742)
46. L. Casciola-Rosen K. Nagaraju P. Plotz, et al. 2005 Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy J Exp Med 201 591 601 15728237 10.1084/jem.20041367 1:CAS:528:DC%2BD2MXhs1Kmsbw%3D (Pubitemid 40289549)
47. A.N. Theofilopoulos R. Baccala B. Beutler D.H. Kono 2005 Type I interferons (alpha/beta) in immunity and autoimmunity Annu Rev Immunol 23 307 336 15771573 10.1146/annurev.immunol.23.021704.115843 1:CAS:528: DC%2BD2MXktFOjur8%3D (Pubitemid 40563172)
48. M.L. Eloranta S. Barbasso Helmers A.K. Ulfgren, et al. 2007 A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies Arthritis Rheum 56 3112 3124 17763410 10.1002/art.22860 1:CAS:528:DC%2BD2sXht1GgtbrO (Pubitemid 47502759)
49. Z. Tezak E.P. Hoffman J.L. Lutz, et al. 2002 Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis J Immunol 168 4154 4163 11937576 1:CAS:528:DC%2BD38XivV2isbo%3D
50. R. Raju M.C. Dalakas 2005 Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes Brain 128 Pt8 1887 1896 15857930 10.1093/brain/awh518 (Pubitemid 41373661)
51. J. Wenzel R. Schmidt J. Proelss, et al. 2006 Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis Clin Exp Dermatol 31 576 582 16716166 10.1111/j.1365-2230.2006.02150.x 1:STN:280: DC%2BD283oslSluw%3D%3D (Pubitemid 43806596)
52. K.A. O'Connor K.A. Abbott B. Sabin, et al. 2006 MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement Clin Immunol 120 319 325 16859997 10.1016/j.clim.2006.05.011 (Pubitemid 44175902)
53. E.C. Baechler F.M. Batliwalla A.M. Reed, et al. 2006 Gene expression profiling in human autoimmunity Immunol Rev 210 120 137 16623768 10.1111/j.0105-2896.2006.00367.x 1:CAS:528:DC%2BD28Xks1Cjs7g%3D
54. R.J. Walsh S.W. Kong Y. Yao, et al. 2007 Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis Arthritis Rheum 56 3784 3792 17968926 10.1002/art.22928 1:CAS:528:DC%2BD2sXhsVSkt7bL (Pubitemid 350100711)
55. Bilgic H YS, Ytterberg S, McNallan KT, et al.: IL-6 and IFN-regulated genes and chemokines as biomarkers of disease activity in dermatomyositis. Arthritis Rheum 2009, in press.
56. T. Sugiura M. Harigai Y. Kawaguchi, et al. 2002 Increased IL-15 production of muscle cells in polymyositis and dermatomyositis Int Immunol 14 917 924 12147628 10.1093/intimm/dxf062 1:CAS:528:DC%2BD38XmsVKjtbk%3D
57. J.L. De Bleecker B. De Paepe I.E. Vanwalleghem J.M. Schroder 2002 Differential expression of chemokines in inflammatory myopathies Neurology 58 1779 1785 12084877
58. N. Fall K.E. Bove K. Stringer, et al. 2005 Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy Arthritis Rheum 52 3175 3180 16200621 10.1002/art.21303 1:CAS:528:DC%2BD2MXhtF2msrvO (Pubitemid 41447100)
59. D. Michaelis N. Goebels R. Hohlfeld 1993 Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes Am J Pathol 143 1142 1149 8214008 1:CAS:528:DyaK2cXhs1WhsLc%3D
60. D.S. Tews H.H. Goebel 1996 Cytokine expression profile in idiopathic inflammatory myopathies J Neuropathol Exp Neurol 55 342 347 8786392 10.1097/00005072-199603000-00009 1:STN:280:DyaK283gslyhuw%3D%3D
61. M. Tateyama I. Nagano M. Yoshioka, et al. 1997 Expression of tumor necrosis factor-alpha in muscles of polymyositis J Neurol Sci 146 45 51 9077495 10.1016/S0022-510X(96)00280-8 1:CAS:528:DyaK2sXitFagsb4%3D (Pubitemid 27116052)
62. T.O. Fedczyna J. Lutz L.M. Pachman 2001 Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele Clin Immunol 100 236 239 11465953 10.1006/clim.2001.5063 1:CAS:528:DC%2BD3MXmsV2mt7s%3D (Pubitemid 32703429)
63. L.M. Pachman M.R. Liotta-Davis D.K. Hong, et al. 2000 TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications Arthritis Rheum 43 2368 2377 11037898 10.1002/1529-0131(200010)43:10<2368:: AID-ANR26>3.0.CO;2-8 1:CAS:528:DC%2BD3cXnslWjsLY%3D (Pubitemid 30783157)
64. J.L. De Bleecker V.I. Meire W. Declercq E.H. Van Aken 1999 Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies Neuromuscul Disord 9 239 246 10399751 10.1016/S0960-8966(98)00126-6 (Pubitemid 29287259)
65. C. Dorph P. Englund I. Nennesmo I.E. Lundberg 2006 Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis Ann Rheum Dis 65 1565 1571 16831829 10.1136/ard.2005.051086 1:CAS:528:DC%2BD28XhtlCntLzN (Pubitemid 44799666)
66. H. Lepidi V. Frances D. Figarella-Branger, et al. 1998 Local expression of cytokines in idiopathic inflammatory myopathies Neuropathol Appl Neurobiol 24 73 79 9549732 10.1046/j.1365-2990.1998.00092.x 1:CAS:528:DyaK1cXitlCgs7Y%3D (Pubitemid 28105417)
67. C. Grundtman S. Salomonsson C. Dorph, et al. 2007 Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies Arthritis Rheum 56 674 687 17265504 10.1002/art.22388 (Pubitemid 46271995)